PlainRecalls
FDA Drug Moderate Class II Ongoing

Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219 NDC's 41167-0300-0, 41167-0300-1, 41167-0300-3, 41167-0300-5, 41167-0300-6, 41167-0300-7, 41167-0300-8

Reported: December 11, 2019 Initiated: October 22, 2019 #D-0535-2020

Product Description

Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219 NDC's 41167-0300-0, 41167-0300-1, 41167-0300-3, 41167-0300-5, 41167-0300-6, 41167-0300-7, 41167-0300-8

Reason for Recall

CGMP Deviations: Presence of NDMA impurity detected in product.

Details

Recalling Firm
Sanofi-Aventis U.S. LLC
Distribution
Nationwide
Location
Bridgewater, NJ

Frequently Asked Questions

What product was recalled?
Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219 NDC's 41167-0300-0, 41167-0300-1, 41167-0300-3, 41167-0300-5, 41167-0300-6, 41167-0300-7, 41167-0300-8. Recalled by Sanofi-Aventis U.S. LLC.
Why was this product recalled?
CGMP Deviations: Presence of NDMA impurity detected in product.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 11, 2019. Severity: Moderate. Recall number: D-0535-2020.